Ocular Toxoplasmosis: No Stranger to the Masquerade Ball

被引:0
|
作者
Dillon, Alexander B. [1 ]
Budoff, Greg [1 ]
McCannel, Colin A. [1 ]
Tsui, Edmund [2 ]
Pullarkat, Sheeja T. [3 ]
Schwartz, Steven D. [1 ]
机构
[1] Univ Calif Los Angeles, Vitreoretinal Surg Serv, Jules Stein Eye Inst, 200 Stein Pl, Los Angeles, CA 90025 USA
[2] Univ Calif Los Angeles, Uveitis Serv, Jules Stein Eye Inst, Los Angeles, CA 90025 USA
[3] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90025 USA
关键词
acute retinal necrosis; masquerade; ocular toxoplasmosis; retina; uveitis; vitreoretinal lymphoma; GOLDMANN-WITMER COEFFICIENT; REAL-TIME PCR; INTRAVITREAL CLINDAMYCIN; RANDOMIZED-TRIAL; RETINOCHOROIDITIS; DIAGNOSIS; AZITHROMYCIN; TRIMETHOPRIM/SULFAMETHOXAZOLE; PYRIMETHAMINE; EPIDEMIOLOGY;
D O I
10.1177/24741264211056769
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: This article illustrates multiple atypical manifestations of ocular toxoplasmosis masquerading as acute retinal necrosis and vitreoretinal lymphoma. Methods: Two case presentations are discussed, and the body of pertinent literature is reviewed and discussed. Results: In these cases, an extensive workup and attention to history lead to the correct diagnosis and management. Conclusions: Aggressive cases of ocular toxoplasmosis may present in a variety of phenotypes that may mimic other vision- and potentially life-threatening conditions, particularly in a milieu of inadequate endogenous and exogenous antimicrobial defenses.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 50 条
  • [1] Therapy for Ocular Toxoplasmosis
    de-la-Torre, Alejandra
    Stanford, Miles
    Curi, Andre
    Jaffe, Glenn J.
    Gomez-Marin, Jorge E.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2011, 19 (05) : 314 - 320
  • [2] Corticosteroids as adjuvant therapy for ocular toxoplasmosis
    Jasper, Smitha
    Vedula, Satyanarayana S.
    John, Sheeja S.
    Horo, Saban
    Sepah, Yasir J.
    Quan Dong Nguyen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (01):
  • [3] Ocular toxoplasmosis II: clinical features, pathology and management
    Butler, Nicholas J.
    Furtado, Joao M.
    Winthrop, Kevin L.
    Smith, Justine R.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 (01) : 95 - 108
  • [4] Ocular Toxoplasmosis
    Goh, Eunice Jin Hui
    Putera, Ikhwanuliman
    Nora, Rina La Distia
    Mahendradas, Padmamalini
    Biswas, Jyotirmay
    Chee, Soon-Phaik
    Testi, Ilaria
    Pavesio, Carlos E.
    Curi, Andre Luiz Land
    Vasconcelos-Santos, Daniel Vitor
    Arora, Atul
    Gupta, Vishali
    de-la-Torre, Alejandra
    Agrawal, Rupesh
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2023, 31 (07) : 1342 - 1361
  • [5] Ocular toxoplasmosis - an update and review of the literature
    Commodaro, Alessandra G.
    Belfort, Rubens N.
    Rizzo, Luiz Vicente
    Muccioli, Cristina
    Silveira, Claudio
    Burnier, Miguel N., Jr.
    Belfort, Rubens, Jr.
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2009, 104 (02): : 345 - 350
  • [6] Ocular manifestations of systemic disease: toxoplasmosis
    Vasconcelos-Santos, Daniel V.
    CURRENT OPINION IN OPHTHALMOLOGY, 2012, 23 (06) : 543 - 550
  • [7] Corticosteroids for ocular toxoplasmosis
    Jasper, Smitha
    Vedula, Satyanarayana S.
    John, Sheeja S.
    Horo, Saban
    Sepah, Yasir J.
    Quan Dong Nguyen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (04):
  • [8] Fulminant Ocular Toxoplasmosis: The Hazards of Corticosteroid Monotherapy
    Oray, Merih
    Ozdal, Pinar Cakar
    Cebeci, Zafer
    Kir, Nur
    Tugal-Tutkun, Ilknur
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2016, 24 (06) : 637 - 646
  • [9] Recent Developments in the Diagnosis and Treatment of Ocular Toxoplasmosis
    Ozgonul, Cem
    Besirli, Cagri Giray
    OPHTHALMIC RESEARCH, 2017, 57 (01) : 1 - 12
  • [10] Ocular toxoplasmosis: background and evidence for an antibiotic prophylaxis
    Reich, Michael
    Mackensen, Friederike
    CURRENT OPINION IN OPHTHALMOLOGY, 2015, 26 (06) : 498 - 505